NIH-funded research R01 grant

Using ketamine to enhance the body's natural pain relief system

Official title: Enhancement of the endogenous opioid system by ketamine

Funded at Icahn School of Medicine at Mount Sinai · NIH-11078223 · Data updated 2026-11-12

This study is looking at how ketamine, a medication often used for anesthesia, affects the body's natural pain and mood control system, with the goal of finding better treatments for chronic pain, depression, and issues with opioid use.

More Ketamine research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionIcahn School of Medicine at Mount Sinai
NIH-funded
Lab location1 site (New York, United States)
Project startJuly 1, 2023
Project endApril 30, 2027
Funding year2025
Award (this year)$557,202
NIH project number5R01DA058681-03
Project IDNIH-11078223 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals suffering from chronic pain, major depressive disorder, or those struggling with opioid use disorder.

Less likely to help

Patients who do not have any of the targeted conditions or who are not responsive to ketamine may not benefit from this research.

What this research studies

This research investigates how ketamine, a medication known for its anesthetic properties, interacts with the body's natural opioid system, which plays a crucial role in pain management and mood regulation. The study aims to understand both the immediate and lasting effects of ketamine on opioid receptors, which could lead to new treatments for conditions like chronic pain, major depressive disorder, and opioid use disorder. By examining these interactions, the research hopes to uncover mechanisms that could improve patient outcomes and provide insights into effective pain relief strategies.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for pain management and mental health disorders, potentially reducing reliance on traditional opioids.

How similar studies have gone: Previous studies have shown promising results in using ketamine for pain and depression, indicating that this approach may be effective.

Where this research is happening

  • Icahn School of Medicine at Mount Sinai
    New York, United States
    Active

Researchers

  • Principal investigator: Devi, Lakshmi a — Icahn School of Medicine at Mount Sinai
  • Study coordinator: Devi, Lakshmi a

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.